Literature DB >> 30495993

Work-Related Stressors and Increased Risk of Benzodiazepine Long-Term Use: Findings From the CONSTANCES Population-Based Cohort.

Guillaume Airagnes1, Cédric Lemogne1, Romain Olekhnovitch1, Yves Roquelaure1, Nicolas Hoertel1, Marcel Goldberg1, Frédéric Limosin1, Marie Zins1.   

Abstract

Objectives. To examine whether stressful job exposure to the public could be associated with having long-term benzodiazepine use.Methods. From the participants included between 2012 and 2016 in the French population-based CONSTANCES cohort, 13 934 men and 19 261 women declared a daily job exposure to the public and rated the frequency of stressful exposure. We examined benzodiazepine long-term use by using drug reimbursement administrative registries. Logistic regressions provided odds ratios (ORs) of benzodiazepine long-term use, with stratification for gender and adjustment for age, education, and area deprivation index. Occupational grade, job strain, depression, self-rated health, and alcohol use disorder were additional stratification variables.Results. Benzodiazepine long-term use was positively associated with stressful exposure to the public ("often or always" vs "rarely or never") in men (OR = 2.2; 95% confidence interval [CI] = 1.8, 2.8) and women (OR = 1.6; 95% CI = 1.4, 1.9), with dose-dependent relationships (P trends < .001). Adjustments and analyses in subgroups without other individual or environmental vulnerability factors led to similar results.Conclusions. Stressful job exposure to the public increases the risk of benzodiazepine long-term use. Prevention programs aiming at reducing the burden of benzodiazepine long-term use would benefit in targeting this specific population.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30495993      PMCID: PMC6301405          DOI: 10.2105/AJPH.2018.304734

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  28 in total

Review 1.  Physician wellness: a missing quality indicator.

Authors:  Jean E Wallace; Jane B Lemaire; William A Ghali
Journal:  Lancet       Date:  2009-11-14       Impact factor: 79.321

2.  Work-related stress and cognitive enhancement among university teachers.

Authors:  Constantin Wiegel; Sebastian Sattler; Anja S Göritz; Martin Diewald
Journal:  Anxiety Stress Coping       Date:  2015-04-10

Review 3.  Treatment of Benzodiazepine Dependence.

Authors:  Michael Soyka
Journal:  N Engl J Med       Date:  2017-03-23       Impact factor: 91.245

4.  Workplace bullying and psychotropic drug use: the mediating role of physical and mental health status.

Authors:  Isabelle Niedhammer; Simone David; Stéphanie Degioanni; Anne Drummond; Pierre Philip; D Acquarone; F Aicardi; P André-Mazeaud; M Arsento; R Astier; H Baille; F Bajon-Thery; E Barre; C Basire; J L Battu; S Baudry; C Beatini; N Beaud'huin; C Becker; D Bellezza; C Beque; O Bernstein; C Beyssier; F Blanc-Cascio; N Blanchet; C Blondel; R Boisselot; G Bordes-Dupuy; N Borrelly; D Bouhnik; M F Boulanger; J Boulard; P Bourreau; D Bourret; A M Boustière; C Breton; G Bugeon; M Buono-Michel; J F Canonne; D Capella; M Cavin-Rey; C Cervoni; D Charreton; D Charrier; M A Chauvin; B Chazal; C Cougnot; G Cuvelier; G Dalivoust; R Daumas; A Debaille; L De Bretteville; G Delaforge; A Delchambre; L Domeny; Y Donati; J Ducord-Chapelet; C Duran; D Durand-Bruguerolle; D Fabre; A Faivre; R Falleri; G Ferrando; J Ferrari-Galano; M Flutet; J P Fouché; F Fournier; E Freyder; M Galy; A Garcia; G Gazazian; C Gérard; F Girard; M Giuge; C Goyer; C Gravier; A Guyomard; M C Hacquin; E Halimi; T Ibagnes; P Icart; M C Jacquin; B Jaubert; J P Joret; J P Julien; M Kacel; E Kesmedjian; P Lacroix; M Lafon-Borelli; S Lallai; J Laudicina; X Leclercq; S Ledieu; J Leroy; L Leroyer; F Loesche; D Londi; J M Longueville; M C Lotte; S Louvain; M Lozé; M Maculet-Simon; G Magallon; V Marcelot; M C Mareel; P Martin; A M Masse; M Méric; C Milliet; R Mokhtari; A M Monville; B Muller; G Obadia; M Pelser; L Peres; E Perez; M Peyron; F Peyronnin; S Postel; P Presseq; E Pyronnet; C Quinsat; H Raulot-Lapointe; P Rigaud; F Robert; O Robert; K Roger; A Roussel; J P Roux; D Rubini-Remigy; N Sabaté; C Saccomano-Pertus; B Salengro; P Salengro-Trouillez; E Samsom; L Sendra-Gille; C Seyrig; G Stoll; N Tarpinian; M Tavernier; S Tempesta; H Terracol; F Torresani; M F Triglia; V Vandomme; F Vieillard; K Vilmot; N Vital
Journal:  Ann Occup Hyg       Date:  2010-12-20

Review 5.  Women and Addiction.

Authors:  Nassima Ait-Daoud; Derek Blevins; Surbhi Khanna; Sana Sharma; Christopher P Holstege
Journal:  Psychiatr Clin North Am       Date:  2017-03-13

6.  Use of benzodiazepine drugs and perceived job stress in a cohort of working men and women in Belgium. Results from the BELSTRESS-study.

Authors:  Edwin Pelfrene; Peter Vlerick; Michel Moreau; Rudolf P Mak; Marcel Kornitzer; Guy De Backer
Journal:  Soc Sci Med       Date:  2004-07       Impact factor: 4.634

Review 7.  Benzodiazepine Misuse in the Elderly: Risk Factors, Consequences, and Management.

Authors:  Guillaume Airagnes; Antoine Pelissolo; Mélanie Lavallée; Martine Flament; Frédéric Limosin
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

8.  CONSTANCES: a general prospective population-based cohort for occupational and environmental epidemiology: cohort profile.

Authors:  Marcel Goldberg; Matthieu Carton; Alexis Descatha; Annette Leclerc; Yves Roquelaure; Gaëlle Santin; Marie Zins
Journal:  Occup Environ Med       Date:  2016-11-24       Impact factor: 4.402

9.  Job stress across gender: the importance of emotional and intellectual demands and social support in women.

Authors:  Pilar Rivera-Torres; Rafael Angel Araque-Padilla; María José Montero-Simó
Journal:  Int J Environ Res Public Health       Date:  2013-01-14       Impact factor: 3.390

10.  Psychological determinants of the intention to educate patients about benzodiazepines.

Authors:  Geeske Brecht Ten Wolde; A Dijkstra; P Van Empelen; A Knuistingh Neven; F G Zitman
Journal:  Pharm World Sci       Date:  2007-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.